Drug Profile


Alternative Names: Muforan; Muphoran; Mustoforan; Mustophoran; S 10036

Latest Information Update: 14 Apr 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Servier
  • Class Antineoplastics; Nitrosourea compounds; Organophosphorus compounds; Small molecules
  • Mechanism of Action DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Malignant melanoma
  • Discontinued Non-small cell lung cancer

Most Recent Events

  • 14 Apr 2010 Launched for Malignant melanoma in Belgium (IV)
  • 14 Apr 2010 Launched for Malignant melanoma in Greece (IV)
  • 04 May 2004 A study has been added to the Cancer therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top